XyloCor Therapeutics

About:

XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.

Website: http://xylocor.com/

Top Investors: Sofinnova Investments, EQT Life Sciences, Longwood Fund, Lumira Ventures, Fountain Healthcare Partners

Description:

XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease. The company's service focuses on developing gene therapy to stimulate the formation of new coronary blood vessels and serve areas of the heart that are not receiving adequate blood supply, enabling patients with refractory angina who exhausted pharmacologic options to cure their cardiovascular diseases painlessly and cost effectively.